-
Loading metrics
Open Access
Peer-reviewed
Research Article
The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure
-
Arne Yndestad ,
* E-mail: Arne.Yndestad@rr-research.no
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway
⨯ -
Alexandra Vanessa Finsen,
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway
⨯ -
Thor Ueland,
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Section of Endocrinology, Oslo University Hospital Rikshospitalet, Oslo, Norway
⨯ -
Cathrine Husberg,
Affiliations Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway
⨯ -
Christen P. Dahl,
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway
⨯ -
Erik Øie,
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway
⨯ -
Leif Erik Vinge,
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway
⨯ -
Ivar Sjaastad,
Affiliations Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Øystein Sandanger,
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway
⨯ -
Trine Ranheim,
Affiliation Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
⨯ -
Kenneth Dickstein,
Affiliations Division of Cardiology, Stavanger University Hospital, Stavanger, Norway, Faculty of Medicine, University of Bergen, Bergen, Norway
⨯ -
John Kjekshus,
Affiliations Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Jan Kristian Damås,
Affiliation Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
⨯ -
Arnt E. Fiane,
Affiliations Department of Thoracic and Cardiovascular Surgery, Oslo University Hospital Rikshospitalet, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Denise Hilfiker-Kleiner,
Affiliation Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
⨯ -
Martin Lipp,
Affiliation Department of Molecular Tumor Genetics and Immunogenetics, Max-Delbrück Center for Molecular Medicine, Berlin, Germany
⨯ -
Lars Gullestad,
Affiliations Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Geir Christensen,
Affiliations Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ - [ ... ],
-
Pål Aukrust
Affiliations Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway, Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ - [ view all ]
- [ view less ]
The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure
- Arne Yndestad,
- Alexandra Vanessa Finsen,
- Thor Ueland,
- Cathrine Husberg,
- Christen P. Dahl,
- Erik Øie,
- Leif Erik Vinge,
- Ivar Sjaastad,
- Øystein Sandanger,
- Trine Ranheim
- Published: March 12, 2012
- https://doi.org/10.1371/journal.pone.0033038